GT Boston Shareholders, Andrew Tibbetts and Prashant Girinath, are sponsoring the Breakthrough Biotech Builders Series in coordination with Technology Innovation Studio (TINS) and Cambridge Innovation Center (CIC).
This event gathers biotech founders and CEOs to a session with Steve Paul, the Founder and Chair of the Board for Seaport Therapeutics. More sessions are to follow.